25 XP   0   0   10

Oncology Institute Inc
Buy, Hold or Sell?

Let's analyse Oncology Institute Inc together

PenkeI guess you are interested in Oncology Institute Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Oncology Institute Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Oncology Institute Inc

I send you an email if I find something interesting about Oncology Institute Inc.

Quick analysis of Oncology Institute Inc (30 sec.)










What can you expect buying and holding a share of Oncology Institute Inc? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
5.9%

What is your share worth?

Current worth
$0.77
Expected worth in 1 year
$0.08
How sure are you?
23.5%

+ What do you gain per year?

Total Gains per Share
$-0.69
Return On Investment
-58.4%

For what price can you sell your share?

Current Price per Share
$1.18
Expected price per share
$1.07 - $1.89
How sure are you?
50%

1. Valuation of Oncology Institute Inc (5 min.)




Live pricePrice per Share (EOD)

$1.18

Intrinsic Value Per Share

$-8.33 - $-9.76

Total Value Per Share

$-7.57 - $-9.00

2. Growth of Oncology Institute Inc (5 min.)




Is Oncology Institute Inc growing?

Current yearPrevious yearGrowGrow %
How rich?$57m$127.1m-$49.1m-63.0%

How much money is Oncology Institute Inc making?

Current yearPrevious yearGrowGrow %
Making money-$19.9m-$465.5k-$19.4m-97.7%
Net Profit Margin-24.9%0.6%--

How much money comes from the company's main activities?

3. Financial Health of Oncology Institute Inc (5 min.)




4. Comparing to competitors in the Medical Care Facilities industry (5 min.)




  Industry Rankings (Medical Care Facilities)  


Richest
#127 / 186

Most Revenue
#107 / 186

Most Profit
#167 / 186

Most Efficient
#166 / 186

What can you expect buying and holding a share of Oncology Institute Inc? (5 min.)

Welcome investor! Oncology Institute Inc's management wants to use your money to grow the business. In return you get a share of Oncology Institute Inc.

What can you expect buying and holding a share of Oncology Institute Inc?

First you should know what it really means to hold a share of Oncology Institute Inc. And how you can make/lose money.

Speculation

The Price per Share of Oncology Institute Inc is $1.18. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Oncology Institute Inc.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Oncology Institute Inc, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.77. Based on the TTM, the Book Value Change Per Share is $-0.17 per quarter. Based on the YOY, the Book Value Change Per Share is $0.01 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Oncology Institute Inc.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.21-17.5%-0.21-18.1%0.000.3%-0.08-6.7%-0.08-6.5%
Usd Book Value Change Per Share-0.20-16.9%-0.17-14.6%0.011.2%0.054.1%0.053.8%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.20-16.9%-0.17-14.6%0.011.2%0.054.1%0.053.8%
Usd Price Per Share2.04-1.17-4.62-5.87-5.53-
Price to Earnings Ratio-2.47--1.37--11.96--46.73--43.98-
Price-to-Total Gains Ratio-10.23--6.61--36.51--815.85--815.85-
Price to Book Ratio2.66-1.28-2.79-3.00-2.82-
Price-to-Total Gains Ratio-10.23--6.61--36.51--815.85--815.85-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.18
Number of shares847
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.170.05
Usd Total Gains Per Share-0.170.05
Gains per Quarter (847 shares)-145.9340.63
Gains per Year (847 shares)-583.70162.53
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-584-5940162153
20-1168-11780325316
30-1752-17620487479
41-2335-23460650642
51-2919-29300812805
61-3503-35140975968
71-4087-4098011371131
81-4671-4682013001294
91-5255-5266014621457
101-5839-5850016251620

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%2.010.00.016.7%3.013.00.018.8%3.014.00.017.6%3.014.00.017.6%
Book Value Change Per Share0.04.00.00.0%3.09.00.025.0%4.012.00.025.0%4.012.01.023.5%4.012.01.023.5%
Dividend per Share1.00.03.025.0%1.00.011.08.3%1.00.015.06.3%1.00.016.05.9%1.00.016.05.9%
Total Gains per Share0.04.00.00.0%3.09.00.025.0%4.012.00.025.0%4.012.01.023.5%4.012.01.023.5%

Fundamentals of Oncology Institute Inc

About Oncology Institute Inc

The Oncology Institute, Inc., an oncology company, provides various medical oncology services in the United States. The company operates through three segments: Dispensary, Patient Services, and Clinical Trials & Other. It offers physician services, in-house infusion and dispensary, clinical trial, radiation, outpatient blood product transfusion, and patient support services, as well as educational seminars, support groups, and counseling services. The company also provides managing clinical trials, palliative care programs, stem cell transplants services, and other care delivery models associated with non-community-based academic and tertiary care settings; and conducts clinical trials for a range of pharmaceutical and medical device companies. It serves adult and senior cancer patients. The company has a strategic collaboration with Healthly Forge to offer cancer care services to patients in Southern California. The Oncology Institute, Inc. was founded in 2007 and is headquartered in Cerritos, California.

Fundamental data was last updated by Penke on 2024-04-22 02:03:02.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Oncology Institute Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Oncology Institute Inc earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Oncology Institute Inc to the Medical Care Facilities industry mean.
  • A Net Profit Margin of -17.9% means that $-0.18 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Oncology Institute Inc:

  • The MRQ is -17.9%. The company is making a huge loss. -2
  • The TTM is -24.9%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-17.9%TTM-24.9%+7.0%
TTM-24.9%YOY0.6%-25.4%
TTM-24.9%5Y-7.5%-17.4%
5Y-7.5%10Y-7.4%-0.1%
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ-17.9%2.5%-20.4%
TTM-24.9%2.4%-27.3%
YOY0.6%3.5%-2.9%
5Y-7.5%3.1%-10.6%
10Y-7.4%3.7%-11.1%
1.1.2. Return on Assets

Shows how efficient Oncology Institute Inc is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Oncology Institute Inc to the Medical Care Facilities industry mean.
  • -7.0% Return on Assets means that Oncology Institute Inc generated $-0.07 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Oncology Institute Inc:

  • The MRQ is -7.0%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -8.8%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-7.0%TTM-8.8%+1.8%
TTM-8.8%YOY0.1%-8.8%
TTM-8.8%5Y-3.7%-5.0%
5Y-3.7%10Y-3.5%-0.2%
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ-7.0%0.7%-7.7%
TTM-8.8%0.6%-9.4%
YOY0.1%1.1%-1.0%
5Y-3.7%0.9%-4.6%
10Y-3.5%1.2%-4.7%
1.1.3. Return on Equity

Shows how efficient Oncology Institute Inc is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Oncology Institute Inc to the Medical Care Facilities industry mean.
  • -26.9% Return on Equity means Oncology Institute Inc generated $-0.27 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Oncology Institute Inc:

  • The MRQ is -26.9%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -25.4%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-26.9%TTM-25.4%-1.5%
TTM-25.4%YOY-0.5%-24.8%
TTM-25.4%5Y-11.6%-13.7%
5Y-11.6%10Y-11.0%-0.7%
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ-26.9%2.1%-29.0%
TTM-25.4%2.1%-27.5%
YOY-0.5%2.8%-3.3%
5Y-11.6%2.3%-13.9%
10Y-11.0%2.7%-13.7%

1.2. Operating Efficiency of Oncology Institute Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Oncology Institute Inc is operating .

  • Measures how much profit Oncology Institute Inc makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Oncology Institute Inc to the Medical Care Facilities industry mean.
  • An Operating Margin of -17.8% means the company generated $-0.18  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Oncology Institute Inc:

  • The MRQ is -17.8%. The company is operating very inefficient. -2
  • The TTM is -18.1%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-17.8%TTM-18.1%+0.3%
TTM-18.1%YOY-28.9%+10.8%
TTM-18.1%5Y-17.4%-0.8%
5Y-17.4%10Y-16.6%-0.8%
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ-17.8%6.7%-24.5%
TTM-18.1%6.7%-24.8%
YOY-28.9%7.0%-35.9%
5Y-17.4%6.4%-23.8%
10Y-16.6%8.1%-24.7%
1.2.2. Operating Ratio

Measures how efficient Oncology Institute Inc is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Care Facilities industry mean).
  • An Operation Ratio of 1.18 means that the operating costs are $1.18 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Oncology Institute Inc:

  • The MRQ is 1.178. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.186. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.178TTM1.186-0.008
TTM1.186YOY1.289-0.103
TTM1.1865Y1.023+0.163
5Y1.02310Y1.0240.000
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1781.161+0.017
TTM1.1861.105+0.081
YOY1.2891.028+0.261
5Y1.0231.026-0.003
10Y1.0241.004+0.020

1.3. Liquidity of Oncology Institute Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Oncology Institute Inc is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Care Facilities industry mean).
  • A Current Ratio of 4.12 means the company has $4.12 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Oncology Institute Inc:

  • The MRQ is 4.125. The company is very able to pay all its short-term debts. +2
  • The TTM is 3.975. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ4.125TTM3.975+0.150
TTM3.975YOY4.071-0.097
TTM3.9755Y4.124-0.150
5Y4.12410Y3.882+0.243
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ4.1251.285+2.840
TTM3.9751.304+2.671
YOY4.0711.342+2.729
5Y4.1241.385+2.739
10Y3.8821.424+2.458
1.3.2. Quick Ratio

Measures if Oncology Institute Inc is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Oncology Institute Inc to the Medical Care Facilities industry mean.
  • A Quick Ratio of 5.03 means the company can pay off $5.03 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Oncology Institute Inc:

  • The MRQ is 5.034. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 4.671. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ5.034TTM4.671+0.363
TTM4.671YOY4.241+0.430
TTM4.6715Y619.600-614.929
5Y619.60010Y583.153+36.447
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ5.0340.893+4.141
TTM4.6710.946+3.725
YOY4.2411.056+3.185
5Y619.6001.159+618.441
10Y583.1531.146+582.007

1.4. Solvency of Oncology Institute Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Oncology Institute Inc assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Oncology Institute Inc to Medical Care Facilities industry mean.
  • A Debt to Asset Ratio of 0.74 means that Oncology Institute Inc assets are financed with 74.0% credit (debt) and the remaining percentage (100% - 74.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Oncology Institute Inc:

  • The MRQ is 0.740. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.656. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.740TTM0.656+0.084
TTM0.656YOY0.446+0.210
TTM0.6565Y0.492+0.164
5Y0.49210Y0.463+0.029
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ0.7400.518+0.222
TTM0.6560.546+0.110
YOY0.4460.522-0.076
5Y0.4920.564-0.072
10Y0.4630.529-0.066
1.4.2. Debt to Equity Ratio

Measures if Oncology Institute Inc is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Oncology Institute Inc to the Medical Care Facilities industry mean.
  • A Debt to Equity ratio of 284.8% means that company has $2.85 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Oncology Institute Inc:

  • The MRQ is 2.848. The company is unable to pay all its debts with equity. -1
  • The TTM is 1.996. The company is just able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ2.848TTM1.996+0.851
TTM1.996YOY0.857+1.139
TTM1.9965Y1.388+0.608
5Y1.38810Y1.306+0.082
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
MRQ2.8480.912+1.936
TTM1.9960.952+1.044
YOY0.8571.078-0.221
5Y1.3881.231+0.157
10Y1.3061.261+0.045

2. Market Valuation of Oncology Institute Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Oncology Institute Inc generates.

  • Above 15 is considered overpriced but always compare Oncology Institute Inc to the Medical Care Facilities industry mean.
  • A PE ratio of -2.47 means the investor is paying $-2.47 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Oncology Institute Inc:

  • The EOD is -1.432. Based on the earnings, the company is expensive. -2
  • The MRQ is -2.475. Based on the earnings, the company is expensive. -2
  • The TTM is -1.371. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.432MRQ-2.475+1.043
MRQ-2.475TTM-1.371-1.104
TTM-1.371YOY-11.956+10.585
TTM-1.3715Y-46.729+45.358
5Y-46.72910Y-43.981-2.749
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
EOD-1.43211.569-13.001
MRQ-2.47510.707-13.182
TTM-1.37114.196-15.567
YOY-11.95611.894-23.850
5Y-46.72917.599-64.328
10Y-43.98120.381-64.362
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Oncology Institute Inc:

  • The EOD is -4.611. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -7.972. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -3.145. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-4.611MRQ-7.972+3.361
MRQ-7.972TTM-3.145-4.827
TTM-3.145YOY-5.513+2.368
TTM-3.1455Y-330.990+327.844
5Y-330.99010Y-311.520-19.470
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
EOD-4.6118.673-13.284
MRQ-7.9727.539-15.511
TTM-3.1457.539-10.684
YOY-5.5136.337-11.850
5Y-330.9906.951-337.941
10Y-311.5205.303-316.823
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Oncology Institute Inc is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Care Facilities industry mean).
  • A PB ratio of 2.66 means the investor is paying $2.66 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Oncology Institute Inc:

  • The EOD is 1.538. Based on the equity, the company is underpriced. +1
  • The MRQ is 2.658. Based on the equity, the company is underpriced. +1
  • The TTM is 1.275. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.538MRQ2.658-1.121
MRQ2.658TTM1.275+1.383
TTM1.275YOY2.791-1.516
TTM1.2755Y2.997-1.722
5Y2.99710Y2.821+0.176
Compared to industry (Medical Care Facilities)
PeriodCompanyIndustry (mean)+/- 
EOD1.5381.858-0.320
MRQ2.6581.861+0.797
TTM1.2751.942-0.667
YOY2.7912.124+0.667
5Y2.9972.374+0.623
10Y2.8212.501+0.320
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Oncology Institute Inc.

3.1. Institutions holding Oncology Institute Inc

Institutions are holding 57.592% of the shares of Oncology Institute Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31FMR Inc6.44810.00074754083-100-0.0021
2023-09-30Deerfield Management Co4.55740.1036336005200
2023-12-31JOSH ARNOLD INVESTMENT CONSULTANT, LLC2.51783.61781856329-21143-1.1261
2023-12-31Vanguard Group Inc2.41070.00011777393193591.1012
2023-12-31Balyasny Asset Management LLC1.69950.00481253037815458186.3567
2023-12-31Kent Lake Capital LLC1.47190.85491085171901956492.2938
2023-12-31Hongkou Capital LP1.19992.298884689-20000-2.2107
2023-12-31Cincinnati Insurance Co0.94880.02576995006995000
2023-12-31TIFF Advisory Services Inc0.57430.409142340500
2023-12-31ELEMENT POINTE ADVISORS, LLC0.53990.1893980523980520
2023-12-31Geode Capital Management, LLC0.46080.00013397673426611.2163
2023-12-31BlackRock Inc0.3226023784600
2023-12-31Millennium Management LLC0.23790.00021754127809080.2388
2023-12-31State Street Corporation0.137401013002330029.8718
2023-12-31Squarepoint Ops LLC0.13140.000496862968620
2023-12-31Saba Capital Management, LP0.12790.00399426400
2023-12-31Renaissance Technologies Corp0.12110.0003893001700023.5131
2023-12-31Fielder Capital Group LLC0.09520.086570192701920
2023-12-31Northern Trust Corp0.08670639431935543.4085
2023-12-31Diametric Capital, LP0.07880.072158095-97249-62.6024
Total 24.16817.667217818692+3034898+17.0%

3.2. Funds holding Oncology Institute Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-02-29Vanguard Total Stock Mkt Idx Inv1.71350.0002127338400
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr0.5680.00084221267000.1661
2024-02-29Fidelity Extended Market Index0.23980.0009178192-863-0.482
2023-09-30BlackRock Extended Mkt Composite0.1190.000988415884150
2024-02-29Fidelity Total Market Index0.07660.00015688700
2024-02-29Fidelity Nasdaq Composite Index0.06550.00064868500
2024-02-29Fidelity Series Total Market Index0.05970.000144329-1321-2.8938
2024-02-29Vanguard Balanced Index Inv0.05320.00013950000
2023-12-31NT Ext Equity Mkt Idx Fd - NL0.04860.00123614019355115.3113
2024-02-29Vanguard Instl Ttl Stk Mkt Idx InstlPls0.03910.00022906800
2023-10-31Vanguard Instl Ttl Stck Mkt Idx Tr0.03910.000229068-1244316-97.7173
2023-12-31NT Ext Equity Mkt Idx Fd - DC - NL - T20.03910.00122902615570115.7105
2024-03-31NT Ext Equity Mkt Idx Fd - L0.03590.00072670700
2023-12-31Northern Trust Extended Eq Market Idx0.03590.00092670700
2024-02-29Spartan Total Market Index Pool E0.02530.00011883000
2024-02-29Vanguard U.S. Eq Idx £ Acc0.02490.00021851900
2024-02-29Spartan Extended Market Index Pool E0.00930.0005694786314.1847
2024-03-31State St US Extended Mkt Indx NL Cl C0.00610.0004450000
2023-12-31SSgA U.S. Extended Market Index Class I0.00610.0003450000
2023-12-31Victory Extended Market Index0.00490.00136133269.9179
Total 3.20960.01062385143-1121271-47.0%

3.3. Insider Transactions

Insiders are holding 19.708% of the shares of Oncology Institute Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-01-29Havencrest Healthcare PartnersSELL86372.12
2024-01-26Havencrest Healthcare PartnersSELL69792.14
2024-01-24Havencrest Healthcare PartnersSELL249152.3
2024-01-22Havencrest Healthcare PartnersSELL102632.12
2024-01-19Havencrest Healthcare PartnersSELL119862.13
2023-11-17Brad HivelySELL250002.24
2023-11-13Brad HivelySELL470002.52

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Oncology Institute Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.199-0.172-14%0.014-1549%0.048-516%0.045-542%
Book Value Per Share--0.7671.050-27%1.616-53%1.544-50%1.453-47%
Current Ratio--4.1253.975+4%4.071+1%4.124+0%3.882+6%
Debt To Asset Ratio--0.7400.656+13%0.446+66%0.492+50%0.463+60%
Debt To Equity Ratio--2.8481.996+43%0.857+232%1.388+105%1.306+118%
Dividend Per Share---0.000-100%-0%0.000-100%0.000-100%
Eps---0.206-0.213+4%0.004-5133%-0.079-62%-0.076-63%
Free Cash Flow Per Share---0.064-0.138+115%-0.213+233%-0.121+89%-0.116+82%
Free Cash Flow To Equity Per Share---0.088-0.161+83%0.074-218%0.274-132%0.255-135%
Gross Profit Margin--1.0001.0000%1.0000%1.835-45%1.785-44%
Intrinsic Value_10Y_max---9.764--------
Intrinsic Value_10Y_min---8.333--------
Intrinsic Value_1Y_max---0.679--------
Intrinsic Value_1Y_min---0.667--------
Intrinsic Value_3Y_max---2.269--------
Intrinsic Value_3Y_min---2.161--------
Intrinsic Value_5Y_max---4.133--------
Intrinsic Value_5Y_min---3.817--------
Market Cap87689217.280-73%151598307.84086723149.632+75%357339795.490-58%440161869.383-66%414269994.713-63%
Net Profit Margin---0.179-0.249+39%0.006-3326%-0.075-58%-0.074-59%
Operating Margin---0.178-0.181+2%-0.289+62%-0.174-2%-0.166-7%
Operating Ratio--1.1781.186-1%1.289-9%1.023+15%1.024+15%
Pb Ratio1.538-73%2.6581.275+108%2.791-5%2.997-11%2.821-6%
Pe Ratio-1.432+42%-2.475-1.371-45%-11.956+383%-46.729+1788%-43.981+1677%
Price Per Share1.180-73%2.0401.167+75%4.618-56%5.873-65%5.528-63%
Price To Free Cash Flow Ratio-4.611+42%-7.972-3.145-61%-5.513-31%-330.990+4052%-311.520+3808%
Price To Total Gains Ratio-5.915+42%-10.227-6.605-35%-36.512+257%-815.848+7878%-815.848+7878%
Quick Ratio--5.0344.671+8%4.241+19%619.600-99%583.153-99%
Return On Assets---0.070-0.088+26%0.001-13019%-0.037-47%-0.035-50%
Return On Equity---0.269-0.254-5%-0.005-98%-0.116-57%-0.110-59%
Total Gains Per Share---0.199-0.172-14%0.014-1549%0.048-516%0.045-542%
Usd Book Value--57025000.00078000500.000-27%127148750.000-55%116512767.500-51%109659075.294-48%
Usd Book Value Change Per Share---0.199-0.172-14%0.014-1549%0.048-516%0.045-542%
Usd Book Value Per Share--0.7671.050-27%1.616-53%1.544-50%1.453-47%
Usd Dividend Per Share---0.000-100%-0%0.000-100%0.000-100%
Usd Eps---0.206-0.213+4%0.004-5133%-0.079-62%-0.076-63%
Usd Free Cash Flow---4754000.000-10220500.000+115%-16821250.000+254%-9216397.938+94%-8889119.176+87%
Usd Free Cash Flow Per Share---0.064-0.138+115%-0.213+233%-0.121+89%-0.116+82%
Usd Free Cash Flow To Equity Per Share---0.088-0.161+83%0.074-218%0.274-132%0.255-135%
Usd Market Cap87689217.280-73%151598307.84086723149.632+75%357339795.490-58%440161869.383-66%414269994.713-63%
Usd Price Per Share1.180-73%2.0401.167+75%4.618-56%5.873-65%5.528-63%
Usd Profit---15314000.000-19907000.000+30%-465500.000-97%-6398158.563-58%-6139068.529-60%
Usd Revenue--85788000.00081059750.000+6%63120750.000+36%63407410.188+35%61875173.647+39%
Usd Total Gains Per Share---0.199-0.172-14%0.014-1549%0.048-516%0.045-542%
 EOD+3 -5MRQTTM+20 -15YOY+12 -215Y+8 -2810Y+8 -28

4.2. Fundamental Score

Let's check the fundamental score of Oncology Institute Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-1.432
Price to Book Ratio (EOD)Between0-11.538
Net Profit Margin (MRQ)Greater than0-0.179
Operating Margin (MRQ)Greater than0-0.178
Quick Ratio (MRQ)Greater than15.034
Current Ratio (MRQ)Greater than14.125
Debt to Asset Ratio (MRQ)Less than10.740
Debt to Equity Ratio (MRQ)Less than12.848
Return on Equity (MRQ)Greater than0.15-0.269
Return on Assets (MRQ)Greater than0.05-0.070
Total3/10 (30.0%)

4.3. Technical Score

Let's check the technical score of Oncology Institute Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5036.736
Ma 20Greater thanMa 501.350
Ma 50Greater thanMa 1001.575
Ma 100Greater thanMa 2001.723
OpenGreater thanClose1.200
Total2/5 (40.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Interest Expense  2,4502002,650222,672232,695-3,935-1,240
Income Tax Expense  123-7944559936135-222-87



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets219,418
Total Liabilities162,393
Total Stockholder Equity57,025
 As reported
Total Liabilities 162,393
Total Stockholder Equity+ 57,025
Total Assets = 219,418

Assets

Total Assets219,418
Total Current Assets143,493
Long-term Assets75,925
Total Current Assets
Cash And Cash Equivalents 33,488
Short-term Investments 49,367
Net Receivables 42,911
Inventory 13,678
Other Current Assets 4,049
Total Current Assets  (as reported)143,493
Total Current Assets  (calculated)143,493
+/-0
Long-term Assets
Property Plant Equipment 40,052
Goodwill 7,230
Intangible Assets 17,904
Long-term Assets Other 561
Long-term Assets  (as reported)75,925
Long-term Assets  (calculated)65,747
+/- 10,178

Liabilities & Shareholders' Equity

Total Current Liabilities34,788
Long-term Liabilities127,605
Total Stockholder Equity57,025
Total Current Liabilities
Short-term Debt 6,403
Accounts payable 14,429
Other Current Liabilities 13,411
Total Current Liabilities  (as reported)34,788
Total Current Liabilities  (calculated)34,243
+/- 545
Long-term Liabilities
Long term Debt 86,826
Capital Lease Obligations 32,849
Long-term Liabilities Other 365
Long-term Liabilities  (as reported)127,605
Long-term Liabilities  (calculated)120,040
+/- 7,565
Total Stockholder Equity
Common Stock8
Retained Earnings -146,150
Other Stockholders Equity 203,167
Total Stockholder Equity (as reported)57,025
Total Stockholder Equity (calculated)57,025
+/-0
Other
Capital Stock8
Cash and Short Term Investments 82,855
Common Stock Shares Outstanding 73,469
Current Deferred Revenue545
Liabilities and Stockholders Equity 219,418
Net Debt 86,327
Net Invested Capital 143,851
Net Working Capital 108,705
Property Plant and Equipment Gross 46,232
Short Long Term Debt Total 119,815



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312018-12-31
> Total Assets 
0
231,843
231,467
231,396
65,689
231,036
85,803
31,261
203,439
206,512
189,740
283,802
263,749
234,633
229,959
218,353
219,418
219,418218,353229,959234,633263,749283,802189,740206,512203,43931,26185,803231,03665,689231,396231,467231,8430
   > Total Current Assets 
0
1,800
1,345
1,201
29,720
736
48,365
30,325
154,056
139,840
112,205
143,631
130,506
118,962
104,071
152,682
143,493
143,493152,682104,071118,962130,506143,631112,205139,840154,05630,32548,36573629,7201,2011,3451,8000
       Cash And Cash Equivalents 
0
1,507
1,103
999
5,998
573
15,169
1,538
114,299
94,659
64,208
61,425
14,010
15,250
28,892
27,535
33,488
33,48827,53528,89215,25014,01061,42564,20894,659114,2991,53815,1695735,9989991,1031,5070
       Short-term Investments 
0
230,043
230,122
230,195
230,254
230,300
230,007
230,013
0
0
0
29,154
59,796
40,132
10,291
59,877
49,367
49,36759,87710,29140,13259,79629,154000230,013230,007230,300230,254230,195230,122230,0430
       Net Receivables 
0
0
0
0
17,259
18,227
20,563
22,257
21,244
25,792
29,369
35,379
40,521
46,384
46,893
48,906
42,911
42,91148,90646,89346,38440,52135,37929,36925,79221,24422,25720,56318,22717,2590000
       Other Current Assets 
0
0
0
0
2,109
353
7,945
775
12,075
11,619
10,048
7,655
6,918
7,370
5,827
4,190
4,049
4,0494,1905,8277,3706,9187,65510,04811,61912,0757757,9453532,1090000
   > Long-term Assets 
0
230,043
230,122
230,195
35,969
230,300
37,438
936
49,383
66,672
77,535
140,171
133,243
115,671
125,888
65,671
75,925
75,92565,671125,888115,671133,243140,17177,53566,67249,38393637,438230,30035,969230,195230,122230,0430
       Property Plant Equipment 
0
0
0
0
2,104
2,561
2,793
3,517
4,192
22,142
23,269
31,814
33,041
34,524
39,813
39,320
40,052
40,05239,32039,81334,52433,04131,81423,26922,1424,1923,5172,7932,5612,1040000
       Goodwill 
0
0
0
0
14,227
0
15,680
150
26,626
26,626
34,476
31,016
23,414
4,551
7,230
7,230
7,230
7,2307,2307,2304,55123,41431,01634,47626,62626,62615015,680014,2270000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
58,215
58,354
58,841
58,944
0
0
0058,94458,84158,35458,21500000000000
       Intangible Assets 
0
0
0
0
19,516
0
18,782
479
18,245
17,572
19,383
18,665
17,957
17,228
19,344
18,561
17,904
17,90418,56119,34417,22817,95718,66519,38317,57218,24547918,782019,5160000
       Other Assets 
0
0
0
0
0
160
183
2,176
320
332
407
461
477
0
557
0
0
0055704774614073323202,17618316000000
> Total Liabilities 
0
6,691
6,431
6,497
37,587
19,386
35,399
57,056
99,280
74,514
65,757
155,868
139,069
136,227
145,237
146,504
162,393
162,393146,504145,237136,227139,069155,86865,75774,51499,28057,05635,39919,38637,5876,4976,4316,6910
   > Total Current Liabilities 
0
391
131
197
28,607
172
27,492
56,160
29,798
31,521
36,128
32,852
29,853
30,085
33,506
32,390
34,788
34,78832,39033,50630,08529,85332,85236,12831,52129,79856,16027,49217228,6071971313910
       Short-term Debt 
0
0
0
0
5,368
0
188
4,895
183
4,277
4,486
5,163
5,498
5,639
6,001
6,079
6,403
6,4036,0796,0015,6395,4985,1634,4864,2771834,89518805,3680000
       Short Long Term Debt 
0
0
0
0
5,368
0
188
0
183
0
0
0
0
0
0
0
0
00000000183018805,3680000
       Accounts payable 
0
288
0
1
12,643
25
13,714
17,695
15,559
12,596
13,900
11,155
9,372
11,946
13,123
13,333
14,429
14,42913,33313,12311,9469,37211,15513,90012,59615,55917,69513,7142512,643102880
       Other Current Liabilities 
0
103
131
196
9,452
147
11,813
27,410
13,464
14,428
16,394
15,256
13,844
11,625
14,126
12,433
13,411
13,41112,43314,12611,62513,84415,25616,39414,42813,46427,41011,8131479,4521961311030
   > Long-term Liabilities 
0
6,300
6,300
6,300
8,980
19,215
7,907
896
69,482
42,993
29,629
123,016
109,216
106,142
111,731
114,114
127,605
127,605114,114111,731106,142109,216123,01629,62942,99369,4828967,90719,2158,9806,3006,3006,3000
       Warrants
0
0
0
0
0
0
0
230,000
0
0
0
0
0
0
0
0
0
000000000230,0000000000
       Other Liabilities 
0
0
0
0
0
2,994
3,217
1,518
69,482
28,584
14,951
22,119
6,089
0
1,276
0
0
001,27606,08922,11914,95128,58469,4821,5183,2172,99400000
> Total Stockholder Equity
0
5,000
5,000
5,000
28,102
5,000
50,404
-52,630
104,159
131,998
123,983
127,934
124,680
98,406
84,722
71,849
57,025
57,02571,84984,72298,406124,680127,934123,983131,998104,159-52,63050,4045,00028,1025,0005,0005,0000
   Common Stock
0
220,153
220,037
219,899
219,756
206,651
200,530
230,001
7
7
7
7
7
7
7
8
8
887777777230,001200,530206,651219,756219,899220,037220,1530
   Retained Earnings Total Equity00-109,9770-63,082-52,075-49,401-43,948-63,234-24,9030000000
   Accumulated Other Comprehensive Income 0000000-206,51200-200,5300-219,7560000
   Capital Surplus 
0
0
0
0
0
0
0
0
167,386
175,939
173,377
180,002
186,250
0
195,586
0
0
00195,5860186,250180,002173,377175,939167,38600000000
   Treasury Stock00000000000000000
   Other Stockholders Equity 
0
-215,105
-214,874
-214,599
294
-198,994
387
-229,554
167,386
175,939
-16,363
180,002
186,250
191,479
194,692
199,237
203,167
203,167199,237194,692191,479186,250180,002-16,363175,939167,386-229,554387-198,994294-214,599-214,874-215,1050



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue324,239
Cost of Revenue-270,539
Gross Profit53,70053,700
 
Operating Income (+$)
Gross Profit53,700
Operating Expense-113,737
Operating Income-60,037-60,037
 
Operating Expense (+$)
Research Development0
Selling General Administrative115,333
Selling And Marketing Expenses0
Operating Expense113,737115,333
 
Net Interest Income (+$)
Interest Income0
Interest Expense-6,777
Other Finance Cost-509
Net Interest Income-7,286
 
Pretax Income (+$)
Operating Income-60,037
Net Interest Income-7,286
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-83,104-36,970
EBIT - interestExpense = -66,814
-67,913
-61,100
Interest Expense6,777
Earnings Before Interest and Taxes (EBIT)-60,037-76,327
Earnings Before Interest and Taxes (EBITDA)-54,164
 
After tax Income (+$)
Income Before Tax-83,104
Tax Provision--89
Net Income From Continuing Ops-75,321-83,015
Net Income-67,877
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses384,276
Total Other Income/Expenses Net-23,0677,286
 

Technical Analysis of Oncology Institute Inc
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Oncology Institute Inc. The general trend of Oncology Institute Inc is BEARISH with 57.1% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Oncology Institute Inc's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-57.1%) Bearish trend (57.1%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Oncology Institute Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 1.3 < 1.63 < 1.89.

The bearish price targets are: 1.08 > 1.08 > 1.07.

Tweet this
Oncology Institute Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Oncology Institute Inc. The current mas is .

The long score for the Moving Averages is 3/14.
The longshort score for the Moving Averages is -8/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Oncology Institute Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Oncology Institute Inc. The current macd is -0.12748428.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Oncology Institute Inc price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Oncology Institute Inc. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Oncology Institute Inc price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Oncology Institute Inc Daily Moving Average Convergence/Divergence (MACD) ChartOncology Institute Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Oncology Institute Inc. The current adx is 18.04.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -1/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Oncology Institute Inc shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Oncology Institute Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Oncology Institute Inc. The current sar is 1.3523601.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Oncology Institute Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Oncology Institute Inc. The current rsi is 36.74. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -4/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
  • Trending down: The RSI is trending down. -1
Oncology Institute Inc Daily Relative Strength Index (RSI) ChartOncology Institute Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Oncology Institute Inc. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Oncology Institute Inc price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Oncology Institute Inc Daily Stochastic Oscillator ChartOncology Institute Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Oncology Institute Inc. The current cci is -64.22285195.

Oncology Institute Inc Daily Commodity Channel Index (CCI) ChartOncology Institute Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Oncology Institute Inc. The current cmo is -28.04499647.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Oncology Institute Inc Daily Chande Momentum Oscillator (CMO) ChartOncology Institute Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Oncology Institute Inc. The current willr is -88.23529412.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
Oncology Institute Inc Daily Williams %R ChartOncology Institute Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Oncology Institute Inc.

Oncology Institute Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Oncology Institute Inc. The current atr is 0.1348082.

Oncology Institute Inc Daily Average True Range (ATR) ChartOncology Institute Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Oncology Institute Inc. The current obv is -28,637,660.

Oncology Institute Inc Daily On-Balance Volume (OBV) ChartOncology Institute Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Oncology Institute Inc. The current mfi is 36.39.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Oncology Institute Inc Daily Money Flow Index (MFI) ChartOncology Institute Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Oncology Institute Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-04STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-05STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-11STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2023-12-13STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-14RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2023-12-15SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2023-12-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-20WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-22WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-26CCI LONG ENTRY SHORT CLOSE100 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-02BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-01-05MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-01-08SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-17MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-24SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-01-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-31CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-01STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-07DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-09DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-12STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-14STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-15WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-21STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-23STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-01SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-06BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-11STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-15STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-18WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-19MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-28DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-08DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-09STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-10DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-15BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-17STOCH SHORT EXITThe %K line crosses above the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-19STOCH LONG EXITThe %K line crosses below the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-23STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-25STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Oncology Institute Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Oncology Institute Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5036.736
Ma 20Greater thanMa 501.350
Ma 50Greater thanMa 1001.575
Ma 100Greater thanMa 2001.723
OpenGreater thanClose1.200
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Oncology Institute Inc with someone you think should read this too:
  • Are you bullish or bearish on Oncology Institute Inc? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Oncology Institute Inc? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Oncology Institute Inc

I send you an email if I find something interesting about Oncology Institute Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Oncology Institute Inc.

Receive notifications about Oncology Institute Inc in your mailbox!